Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases
- PMID: 18220954
- DOI: 10.2174/187152807783334319
Gastrin-releasing peptide receptor as a molecular target for inflammatory diseases
Abstract
Bombesin-like peptides (BLP) and its receptors are widely distributed in mammalian peripheral tissues and in the central nervous system. Recently, effects of these peptides on the production and release of cytokines were described both in animal models and humans with inflammatory diseases. Some pathological conditions such as exposure to tobacco smoke, chronic obstructive pulmonary diseases and eosinophilic granuloma have recently been found to be associated with an increase of pulmonary BLP-producing cells. Proinflammatory neuropeptides have a key role in the pathogenesis and maintenance of rheumatoid arthritis and sepsis. Together, these findings support the view that the GRPR should be considered a therapeutic target for a subset of inflammatory diseases.
Similar articles
-
Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling.Mol Med. 2012 Oct 24;18(1):1209-19. doi: 10.2119/molmed.2012.00083. Mol Med. 2012. PMID: 22735756 Free PMC article. Clinical Trial.
-
Gastrin-releasing peptide as a molecular target for inflammatory diseases: an update.Inflamm Allergy Drug Targets. 2013 Jun;12(3):172-7. doi: 10.2174/1871528111312030003. Inflamm Allergy Drug Targets. 2013. PMID: 23621446 Review.
-
Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5300-3. doi: 10.1167/iovs.09-3525. Epub 2009 Jun 10. Invest Ophthalmol Vis Sci. 2009. PMID: 19516017
-
Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils.Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):547-52. doi: 10.1073/pnas.1110996109. Epub 2011 Dec 27. Proc Natl Acad Sci U S A. 2012. PMID: 22203955 Free PMC article.
-
Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications.Curr Drug Targets. 2016;17(5):508-14. doi: 10.2174/1389450116666151001112130. Curr Drug Targets. 2016. PMID: 26424393 Review.
Cited by
-
Regulatory Peptides in Asthma.Int J Mol Sci. 2021 Dec 20;22(24):13656. doi: 10.3390/ijms222413656. Int J Mol Sci. 2021. PMID: 34948451 Free PMC article. Review.
-
Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling.Mol Med. 2012 Oct 24;18(1):1209-19. doi: 10.2119/molmed.2012.00083. Mol Med. 2012. PMID: 22735756 Free PMC article. Clinical Trial.
-
Facilitation of the inhibitory transmission by gastrin-releasing peptide in the anterior cingulate cortex.Mol Pain. 2010 Sep 13;6:52. doi: 10.1186/1744-8069-6-52. Mol Pain. 2010. PMID: 20836873 Free PMC article.
-
Effects of the gastrin-releasing peptide antagonist RC-3095 in a rat model of ulcerative colitis.Dig Dis Sci. 2010 Aug;55(8):2203-10. doi: 10.1007/s10620-009-1032-9. Epub 2009 Nov 6. Dig Dis Sci. 2010. PMID: 19894117
-
Design, synthesis and evaluation of PD176252 analogues for ameliorating cisplatin-induced nephrotoxicity.Medchemcomm. 2019 Apr 11;10(5):757-763. doi: 10.1039/c8md00632f. eCollection 2019 May 1. Medchemcomm. 2019. PMID: 31191866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources